Trademark: 87299354
Word
ENVENTRA
Status
Dead
Status Code
710
Status Date
Friday, December 15, 2023
Serial Number
87299354
Registration Number
5214267
Registration Date
Tuesday, May 30, 2017
Mark Type
4000
Filing Date
Thursday, January 12, 2017
Published for Opposition
Tuesday, March 14, 2017
Cancellation Date
Friday, December 15, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Dec 15, 2023
Cancelled Sec. 8 (6-Yr)
Nov 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Teas Change Of Domestic Representatives Address
Nov 8, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 8, 2022
Teas Change Of Owner Address Received
May 30, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 30, 2017
Registered-Principal Register
Mar 14, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2017
Published For Opposition
Feb 22, 2017
Notification Of Notice Of Publication E-Mailed
Jan 31, 2017
Approved For Pub - Principal Register
Jan 27, 2017
Assigned To Examiner
Jan 19, 2017
New Application Office Supplied Data Entered
Jan 16, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24